BioHealth News Archive
World class drug discovery team launches new company to tackle chronic respiratory disease
Enterprise Therapeutics Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured £1.6m ($2.4m) in initial…
Read MoreScience Talent Competition Highlights Student Innovation – University of Maryland, Baltimore
In today’s world, the average adult between the ages of 65 and 69 takes almost 14 prescriptions per year, and those aged 80-84 take…
Read MoreRFP: GMP Facility – Institute for Bioscience and Biotechnology Research
This is a Request for Proposal to lease the Good Manufacturing Practices (GMP) facility located at the Institute for Bioscience and Biotechnology Research (IBBR),…
Read MoreSee these photos of Johns Hopkins’ new East Baltimore incubator – Technical.ly Baltimore
Johns Hopkins University President Ronald Daniels has seen plenty of innovation at the world-renowned research institution he leads. In opening a second incubator in East…
Read MoreSucampo inks licence agreement with Par Pharmaceutical for generic Rescula
Sucampo Pharmaceuticals, a global biopharmaceutical company, announced that Sucampo and R-Tech Ueno, Ltd. (RTU), have entered into a stipulation and licence agreement with Par…
Read MoreHere’s how an angel investor tax credit program would work in Maryland – Baltimore Business Journal
Maryland could establish a $5 million fund to put toward tax credits for individuals and firms who invest in startup companies. Startup and investor…
Read MoreThese Maryland public colleges are among the top 100 in the U.S. – Baltimore Business Journal
Four University System of Maryland schools rank among the top 100 public universities in the country, according to a new statistical analysis by The…
Read MoreWorld Medical Innovation Forum- Eventbrite
April 27-29, 2015 - Boston, MA Partners HealthCare is proud to announce the 2015 World Medical Innovation Forum, an annual gathering in Boston of…
Read MoreThe Road to Personalized Medicine: FDA’s Proposed Guidelines on Companion Diagnostics
While regulation of diagnostic tests by the Food and Drug Administration (FDA) may not directly impact the biobanking industry, it does have an impact on…
Read MoreNIH Opens Discussion: How to Build a U.S. Health Research Database? – Xconomy
National Institutes of Health director Francis Collins kicked off a two-day meeting in Bethesda, MD, this morning to discuss how to turn President Obama’s…
Read MoreViaCyte Starts Stem-Cell Trial of Bioartificial Pancreas – MIT Technology Review
Fourteen years ago, during the darkest moments of the “stem-cell wars” pitting American scientists against the White House of George W. Bush, one group…
Read MoreGSK buys vaccine specialist GlycoVaxyn for $190m – PMLiVE
GlaxoSmithKline (GSK) has taken control of Swiss company GlycoVaxyn in a $190m deal that bolsters its early vaccines pipeline. GSK already owned a stake…
Read MoreReport: How are venture dollars distributed among disease and clinical trial phase?
How are venture capital dollars are actually disseminated? Into early stage companies? Late? What fields get the most investment – cancer? Bruce Booth of…
Read MoreWhy has hardly anyone applied for equity crowdfunding in D.C.? – The Washington Post
District regulators approved the city’s first equity crowdfunding campaign last week. It was also the only application they’ve received to date. The Department of…
Read MoreRoche acquires Germany’s Signature Diagnostics
Swiss cancer drugs giant Roche (ROG: SIX) has acquired Signature Diagnostics, a privately-held company based in Potsdam, Germany. Financial terms of the transaction, which…
Read More